Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The clinic has pioneered innovations that have been adopted nationwide and around the world.
The video series by American Gene Technologies features interviews with HIV advocates, peer leaders, scientists, TikTokers and more.
This year’s most widely viewed science news focused on HIV cure research, monkeypox and PEP for sexually transmitted infections.
EBT-101 is novel gene-editing therapy that uses “molecular scissors” to cut HIV out of cells.
A “living drug” could potentially eliminate HIV-infected cells, allowing for long-term remission without antiretroviral therapy.
The experimental antibody, dubbed N6LS, demonstrated strong antiviral activity in a Phase II study.
A new case may provide clues to help researchers develop strategies for a functional cure.
While the risky procedure is not suitable for most people living with HIV, it offers clues for more feasible approaches.
Held in person and virtually, AIDS 2022 is the world’s largest HIV-related gathering. From cure news to advocacy, here’s what to expect.
Two Campbell Foundation grantees hope to find out and better understand the HIV reservoir. Their work could help research for a cure.
Study participation can be a gateway to better therapies for yourself and others.
One person treated with a broadly neutralizing antibody plus romidepsin remained in remission for 3.7 years.
A combination of two antibodies, dubbed 3BNC117 and 10-1074, maintained viral suppression for a year in two people.
An amfAR grant will help find out. Plus, the AIDS research group also awards three new Mathilde Krim HIV fellowships.
The latest Campbell Foundation research grant will help a UCLA scientist study HIV’s ability to mutate during CAR-T gene therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.